2
Disclosures
Jan 13, 2026 — Jan 13, 2026
Date Range
PRIME
Market Segment
Retail Trade
Sector

Disclosures

DateTypeHeadlinePDF
Jan 13 Corporate Action Cosmos Pharma Reorganizes Structure and Promotes Executives PDF
Jan 13 Earnings Cosmos Pharmaceutical Corporation Reports Q2 Revenue of 537 billion, Up 6% PDF

Disclosure Types

Corporate Action: 1 Earnings: 1